Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06873009Not ApplicableEnrolling By Invitation

Can Cognitive Behavioural Therapy Help Incarcerated Men Quit Smoking? Efficacy and Predictors of Treatment Outcomes

Role: collaborator

NCT06650813Not ApplicableRecruiting

Adapting the FACETS Program to Sickle Cell Disease

Role: collaborator

NCT05318651Not ApplicableCompleted

Use Determinants of Smoking Cessation App

Role: lead

NCT04030819Not ApplicableUnknown

Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis

Role: lead

All 4 trials loaded